Newsroom

Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix
14 DEC
Neuraxpharm acquires Medinutrix Ltd to provide an immediate platform for the recently acquired market-leading epilepsy treatment Buccolam® in Ireland
Read more
Permira funds to acquire leading European CNS specialty pharmaceutical company Neuraxpharm
22 SEP
Press release, 22 September 2020
Read more
Neuraxpharm acquires market-leading Buccolam® for emergency treatment of epileptic children
14 SEP
Neuraxpharm announces the acquisition of the prescription brand Buccolam® (oromucosal midazolam) from Takeda, a product indicated for the emergency treatment of epileptic children with prolonged acute convulsive seizures (PACS)
Read more
Neuraxpharm expands Italian product portfolio with a well-established brand from Almirall
26 JUNE
Neuraxpharm Italy acquires Ansiolin^®, an anxiolytic prescription drug
Read more
Neuraxpharm launches the social initiative “Quarantine Together” to provide psychological support to families in Spain and Italy during COVID-19
02 APR
Families will receive free help and guidance in their homes from professional psychologists via telephone or email during times of social distancing
Read more

123 4 5 8

Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix